Preliminary report of multiple cell therapy for patients with multiple system atrophy

Cell Transplantation

Volumn 22, Issue SUPPL.1, 2013, Pages

  Xi, Haitao ^a,b   Chen, Lin ^a,c,d   Huang, Hongyun ^a,c   Zhang, Feng ^a,b   Liu, Yancheng ^a,c   Chen, Di ^a   Xiao, Juan ^a  

^a Beijing Hongtianji Neuroscience Academy   (China)

^b Department of Neurorestoratology   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d TSINGHUA UNIVERSITY   (China)

Author keywords

Comprehensive neurorestoration; Multiple cells; Multiple system atrophy; Transplantation

Indexed keywords

ACUPUNCTURE; ADULT; AGED; ARTICLE; BRAIN TRANSPLANTATION; CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DIZZINESS; FEMALE; FEVER; FOLLOW UP; HEADACHE; HUMAN; INTERNATIONAL COOPERATIVE ATAXIA RATING SCALE; LOCOMOTION; LUNG INFECTION; MALE; MUSCLE TONE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEURAL PROGENITOR CELL TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY ENSHEATHING CELL TRANSPLANTATION; PHYSIOTHERAPY; PNEUMOCEPHALUS; PRIORITY JOURNAL; SCHWANN CELL TRANSPLANTATION; SHY DRAGER SYNDROME; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; UMBILICAL CORD MESENCHYMAL CELL TRANSPLANTATION; UNIFIED MULTIPLE SYSTEM ATROPHY RATING SCALE;

ADULT; AGED; CELL TRANSPLANTATION; CELL- AND TISSUE-BASED THERAPY; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEURAL STEM CELLS; OLFACTORY BULB; OLFACTORY MUCOSA; TREATMENT OUTCOME; UMBILICAL CORD; YOUNG ADULT;

EID: 84890386018     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368913X672145     Document Type: Article

References (60)

1. Bohbot, A. Olfactory ensheathing glia transplantation combined with LASERPONCTURE (R) in human spinal cord injury: Results measured by electromyography monitoring. Cell Transplant. 19:179-184; 2010.
2. Borlongan, C. V. Remyelinating the transected peripheral nerve by fabricated Schwann cells derived from bone marrow. Exp Neurol. 225(2):243-245; 2010.
3. Botero, L.; Gomez, R. M.; Chaparro, O. Pathogenesis of spinal cord injuries and mechanisms of repair induced by olfactory ensheathing cells. Rev. Neurol. 56(10):521-531; 2013
4. Chen, L.; Chen, D.; Xi, H. T.; Wang, Q. M.; Liu, Y. C.; Zhang, F.; Wang, H. M.; Ren, Y. S.; Xiao, J.; Wang, Y. C.; Huang, H. Olfactory ensheathing cell neurorestorotherapy for amyotrophic lateral sclerosis patients: Benefits from multiple transplantations. Cell Transplant. 21(Suppl 1): S65-S77; 2012.
5. Chen, L.; Huang, H.; Xi, H. T.; Xie, Z. H.; Liu, R. W.; Jiang, Z.; Zhang, F.; Liu, Y. C.; Chen, D.; Wang, Q. M.; Wang, H. M.; Ren, Y. Y.; Zhou, C. M. Intracranial transplant of olfactory ensheathing cells in children and adolescents with cerebral palsy: A randomized controlled clinical trial. Cell Transplant. 19(2):185-191; 2010.
6. Chen, L.; Xi, H. T.; Huang, H.; Zhang, F.; Liu, Y. C.; Chen, D.; Jiang, Z.; Wang, Q. M.; Ren, Y. S. Clinical practice of brain key points for neural network restoration. J. Clin. Rehab. Tissue Eng. Res. 15(6):1127-1131; 2011.
7. Constantinescu, R.; Richard, I.; Kurlan, R. Levodopa responsiveness in disorders with Parkinsonism: A review of the literature. Mov. Disord. 22:2141-2148; 2007.
8. Deng, Y. B.; Liu, Y.; Zhu, W. B.; Bi, X. B.; Wang, Y. Z.; Ye, M. H.; Zhou, G. Q. The co-transplantation of human bone marrow stromal cells and embryo olfactory ensheathing cells as a new approach to treat spinal cord injury in a rat model. Cytotherapy 10(6):551-564; 2008.
9. Geffner, L. F.; Santacruz, P.; Izurieta, M.; Flor, L.; Maldonado, B.; Auad, A. H.; Montenegro, X.; Gonzalez, R.; Silva, F. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: Comprehensive case studies. Cell Transplant. 17(12):1277-1293; 2008.
10. Gilman, S.; Wenning, G. K.; Low, P. A.; Brooks, D. J.; Mathias, C. J.; Trojanowski, J. Q.; Wood, N. W.; Colosimo, C.; Dürr, A.; Fowler, C. J.; Kaufmann, H.; Klockgether, T.; Lees, A.; Poewe, W.; Quinn, N.; Revesz, T.; Robertson, D.; Sandroni, P.; Seppi, K.; Vidailhet, M. Second consensus statement on the diagnosis of muhiple system atrophy. Neurology 7l(9):670-676; 2008.
11. Golden, K. L.; Pearse, D. D.; Blits, B.; Garg, M. S.; Oudega, M.; Wood, P. M.; Bunge, M. B. Transduced Schwann cells promote axon growth and myelination after spinal cord injury. Exp. Neurol. 207(2):203-217; 2007.
12. Han, D. M.; Liu, J.; Xue, M.; Zhu, L.; Yan, H. M.; Wang, Z. D.; Ding, L.; Guo, Z. K.; Wang, H. X. Clinical analysis of the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type with umbilical cord mesenchymal stromal cells. Cytotherapy 13(8):913-917; 2011.
13. Huang, H.; Chen, L.; Sanberg, P. R. Cell therapy from bench to bedside translation in CNS neurorestoratology era. Cell Med. 1:15-46; 2010.
14. Huang, H.; Chen, L.; Sanberg, P. R. Clinical achievements, obstacles, falsehoods, and future directions of cell-based neurorestoratology. Cell Transplant. 21(Suppl1):S3-S11; 2012.
15. Huang, H.; Chen, L.; Wang, H. M.; Xiu, B.; Li, B.; Wang, R.; Zhang, J.; Zhang, F.; Gu, Z.; Li, Y.; Song, Y.; Hao, W.; Pang, S.; Sun, J. Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord. Chin. Med. J. 116:1488-1491; 2003.
16. Huang, H.; Chen, L.; Xi, H.; Wang, H.; Zhang, J.; Zhang, F.; Liu, Y. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: A controlled pilot study. Clin. Transplant. 22(6):710-718; 2008.
17. Huang, H.; Chen, L.; Xi, H. T.; Wang, Q. M.; Zhang, J.; Liu, Y. C.; Zhang, F. Olfactory ensheathing cells transplantation for central nervous system diseases in 1255 patients. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 23(1):14-20; 2009.
18. Huang, H.; Xi, H. T.; Chen, L.; Zhang, F.; Liu, Y. C. Longterm outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury. Cell Transplant. 21(Suppl 1):S23-S31; 2012.
19. Jellinger, K. A.; Lantos, P. L. Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: An update. Acta Neuropathol. 119(6):657-667; 2010.
20. Jiang, X. R.; Wang, H. M.; Chen, L.;Tian, G. Z.; Bao, J. L.; Ren, Y. S.; Huang, H. Y.; Xi, H. T. Culture and identification of neural stem/progenitor cells from human embryonic subependymal zone by adherent method. Prog. Anat. Sci. 16(4):307-310; 2010.
21. Kawasaki-Oyama, R. S.; Braile, D. M.; Caldas, H. C.; Leal, J. C.; Goloni-Bertollo, E. M.; Pavarino-Bertelli, E. C.; Abbud Filho, M.; Santos, I. D. Blood mesenchymal stem cell culture from the umbilical cord with and without Ficoll-Paque density gradient method. Rev. Bras. Cir. Cardiovasc. 23(1):29-34; 2008.
22. Kocsis, J. D.; Lankford, K. L.; Sasaki, M.; Radtke, C. Unique in vivo properties of olfactory ensheathing cells that may contribute to neural repair and protection following spinal cord injury. Neurosci. Lett. 456(3):137-142; 2009.
23. Kollensperger, M.; Stefanova, N.; Pallua, A.; Puschban, Z.; Dechant, G.; Hainzer, M.; Reindl, M.; Poewe, W.; Nikkhah, G.; Wenning, G. K. Striatal transplantation in a rodent model of multiple system atrophy: Effects on L-Dopa response. J. Neurosci. Res. 87(7):1679-1685; 2009.
24. Krismer, F.; Seppi, K.; Tison, F.; Sampaio, C.; Zangerl, A.; Peralta, C.; Yekhlef, F.; Ghorayeb, I.; Ory-Magne, F.; Galitzky, M.; Bozi, M.; Scaravilli, T.; Colosimo, C.; Geser, F.; Rascol, O.; Poewe, W.; Quinn, N. P.; Wenning, G. K. The Unified Multiple System Atrophy Rating Scale: Intrarater reliability. Mov. Disord. 27(13):1683-1685; 2012.
25. Lavdas, A. A.; Papastefanaki, F.; Thomaidou, D.; Matsas, R. Schwann cell transplantation for CNS repair. Curr. Med. Chem. 15(2):151-160; 2008.
26. Lee, P. H.; Kim, J. W.; Bang, O. Y.; Ahn, Y. H.; Joo, I. S.; Huh, K. Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin. Pharmacol. Ther. 83(5):723-730; 2008.
27. Lee, P. H.; Lee, J. E.; Kim, H. S.; Song, S. K.; Lee, H. S.; Nam, H. S.; Cheong, J. W.; Jeong, Y.; Park, H. J.; Kim, D. J.; Nam, C. M.; Lee, J. D.; Kim, H. O.; Sohn, Y. H. A randomized trial of mesenchymal stem cells in multiple system atrophy. Ann. Neurol. 72(1):32-40; 2012.
28. Lee, P. H.; Park, H. J. Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy. J. Clin. Neurol. 5:1-10; 2009.
29. Liu, J.; Xue, M.; Zhu, L.; Ding, L.; Yan, H. M.; Wang, Z. D.; Han, D. M.; Wang, H. X. Clinical analysis on the treatment of spinocerebellar ataxia and multiple system atrophycerebellar type with umbilical cord mesenchymal stem cells. J. Tissue Eng. Reconstr. Surg. 6(5):257-260; 2010.
30. Liu, K.; Li, Y.; Wang, H.; Jiang, X.; Zhao, Y.; Sun, D.; Chen, L.; Young, W.; Huang, H.; Zhou, C. The immuno-histochemical characterization of human fetal olfactory bulb and olfactory ensheathing cells in culture as a source for clinical CNS restoration. Anat. Rec. 293:359-369; 2010.
31. Lu, J.; Féron, F.; Ho, S. M.; Mackay-Sim, A.; Waite, P. M. Transplantation of nasal olfactory tissue promotes partial recovery in paraplegic adult rats. Brain Res. 889(1-2):344-357; 2001.
32. Moviglia, G. A.; Fernandez Viña, R.; Brizuela, J. A.; Saslavsky, J.; Vrsalovic, F.; Varela, G.; Bastos, F.; Farina, P.; Etchegaray, G.; Barbieri, M.; Martinez, G.; Picasso, F.; Schmidt, Y.; Brizuela, P.; Gaeta, C. A.; Costanzo, H.; Moviglia Brandolino, M. T.; Merino, S.; Pes, M. E.; Veloso, M. J.; Rugilo, C.; Tamer, I.; Shuster, G. S. Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. Cytotherapy 8(3):202-209; 2006.
33. Moviglia, G. A.; Varela, G.; Brizuela, J. A.; Moviglia Brandolino, M. T.; Farina, P.; Etchegaray, G.; Piccone, S.; Hirsch, J.; Martinez, G.; Marino, S.; Deffain, S.; Coria, N.; Gonzáles, A.; Sztanko, M.; Salas-Zamora, P.; Previgliano, I.; Aingel, V.; Farias, J.; Gaeta, C. A.; Saslavsky, J.; Blasseti, N. Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients. Spinal Cord 47(6):499-503; 2009.
34. Novikova, L. N.; Lobov, S.; Wiberg, M.; Novikov, L. N. Efficacy of olfactory ensheathing cells to support regeneration after spinal cord injury is influenced by method of culture preparation. Exp. Neurol. 229(1):132-142; 2011.
35. Olivier, F.; Wassilios, G. M.; Francois, T. Multiple system atrophy: Current and future approaches to management. Ther. Adv. Neurol. Disord. 3(4):249-263; 2010.
36. Park, H. J.; Bang, G.; Lee, B. R.; Kim, H. O.; Lee, P. H. Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy-parkinsonism. Cell Transplant. 20(6):827-835; 2011.
37. Pearse, D. D.; Sanchez, A. R.; Pereira, F. C.; Andrade, C. M.; Puzis, R.; Pressman, Y.; Golden, K.; Kitay, B. M.; Blits, B.; Wood, P. M.; Bunge, M. B. Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery. Glia 55(9):976-1000; 2007.
38. Pellitteri, R.; Spatuzza, M.; Russo, A.; Stanzani, S. Olfactory ensheathing cells exert a trophic effect on the hypothalamic neurons in vitro. Neurosci. Lett. 417(1):24-29; 2007.
39. Rama, P.; Matuska, S.; Paganoni, G.; Spinelli, A.; De Luca, M.; Pellegrini, G. Limbal stem-cell therapy and long-term corneal regeneration. N. Engl. J. Med. 363:47-55; 2010.
40. Rosner, J.; Avalos, P.; Acosta, F.; Liu, J.; Drazin, D. The potential for cellular therapy combined with growth factors in spinal cord injury. Stem Cells Int. 2012:826754; 2012.
41. Schmeichel, A. M.; Buchhaher, L. C.; Low, P. A.; Parisi, J. E.; Boeve, B. W.; Sandroni, P.; Benarroch, E. E. Mesopontine cholinergic neuron involvement in lewy body dementia and multiple system atrophy. Neurology 70(5):368-373; 2008.
42. Schoch, B.; Regel, J. P.; Frings, M.; Gerwig, M.; Maschke, M.; Neuhäuser, M.; Timmann, D. Reliability and validity of ICARS in focal cerebellar lesions. Mov. Disord. 22(15):2162-2169; 2007.
43. Seledtsova, G. V.; Rabinovich, S. S.; Belogorodtsev, S. N.; Parlyuk, O. V.; Seledtsov, V. I.; Kozlov, V. A. Delayed results of transplantation of fetal neurogenic tissue in patients with consequences of spinal cord trauma. Bull. Exp. Biol. Med. 149(4):530-533; 2010.
44. Stefanova, N.; Hainzer, M.; Stemberger, S.; Couillard-Després, S.; Aigner, L.; Poewe, W.; Wenning, G. K. Striatal transplantation for multiple system atrophy-Are grafts affected by alpha-synucleinopathy? Exp. Neurol. 219(1): 368-371; 2009.
45. Stemberger, S.; Jamnig, A.; Stefanova, N.; Lepperdinger, G.; Reindl, M.; Wenning, G. K. Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: Immunomodulation and neuroprotection. PLoS One 6(5):e19808; 2011.
46. Stemberger, S.; Poewe, W.; Wenning, G. K.; Stefanova, N. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-1ike progressive autonomic failure. Exp. Neurol. 224(2):459-464; 2010.
47. Sun, Z. H.; Xiu, B.; Zuo, H. C. Theory and clinical application of olfactory ensheathing cell transplantation in treatment of central nervous system injury. J. Clin. Rehab. Tissue Eng. Res. 13(5):899-902; 2009.
48. Tian, Z. M.; Chen, T.; Zhong, N.; Li, Z. C.; Yin, F.; Liu, S. Clinical study of transplantation of neuro stem cells in therapy of inherited cerebellar atrophy. J. Peking Univ. 41(4):456-458; 2009.
49. Ubhi, K.; Low, P.; Masliah, E. Multiple system atrophy: A clinical and neuropathological perspective. Trends Neurosci. 34(11):581-590; 2011.
50. Venkataramana, N. K.; Pal, R.; Rao, S. A.; Naik, A. L.; Jan, M.; Nair, R.; Sanjeev, C. C.; Kamble, R. B.; Murthy, D. P.; Chaitanya, K. Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson's disease: A pilot clinical study. Stem Cells Int. 2012:931902; 2012.
51. Wang, H. M.; Hu, Q.; Jiang, X. R.; Xiao, J.; Ren, Y. S.; Chen, L.; Huang, H. Y. Comparison of different culture methods on human embryonic schwann cells. Chin. J. Clin. 5(19):5599-5603; 2011.
52. Weidner, N.; Blesch, A.; Grill, R. J.; Tuszynski, M. H. Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1. J. Comp. Neurol. 413(4):495-506; 1999.
53. Wiliams, R. R.; Bunge, M. B. Schwann cell transplantation: A repair strategy for spinal cord injury? Prog. Brain Res. 201:295-312; 2012.
54. Wu, L. K.; Wang, X. J.; Xu, B. L.; Liu, S. S.; Chu, S. S.; Cheng, B. Umbilical cord blood mesenchymal stem cell transplantation in 20 patients with multiple system Atrophy. J. Clin. Rehab. Tissue Eng. Res. 13(45):8975-8978; 2009.
55. Xi, H. T.; Huang, H. Y.; Chen, L.; Zhang, F.; Liu, Y. C.; Zhang, J. Fetal olfactory ensheathing cell transplantation for treating Friedreich ataxia: An analysis of outcome and safety. J. Clin. Rehabil. Tissue Eng. Res. 12(12):2359-2363; 2008.
56. Xiao, J.; Wang, H. M.; Chen, L.; Ren, Y. S.; Jiang, X. R.; Huang, H. Y.; Li, Y.; Zhao, Y. X. The preparation of human embryo olfactory bulb olfactory ensheathing cells. Prog. Anat. Sci. 17(3):276-279; 2011.
57. Zeng, Y. S.; Ding, Y.; Wu, L. Z.; Guo, J. S.; Li, H. B.; Wong, W. M.; Wu, W. T. Co-transplantation of schwann cells promotes the survival and differentiation of neural stem cells transplanted into the injured spinal cord. Dev. Neurosci. 27(1):20-26; 2005.
58. Zhang, L.; Li, Y.; Romanko, M.; Kramer, B.C.; Gosiewska, A.; Chopp, M.; Hong, K. Different routes of administration of human umbilical tissue-derived cells improve functional recovery in the rat after focal cerebral ischemia. Brain Res. 1489:104-112; 2012.
59. Ziegler, M. D.; Hsu, D.; Takeoka, A.; Zhong, H.; Ramón-Cueto, A.; Phelps, P. E.; Roy, R. R.; Edgerton, V. R. Further evidence of olfactory ensheathing glia facilitating axonal regeneration after a complete spinal cord transection. Exp. Neurol. 229(1):109-119; 2011.
60. Zujovic, V.; Doucerain, C.; Hidalgo, A.; Bachelin, C.; Lachapelle, F.; Weissert, R.; Stadelmann, C.; Linington, C.; Baron-Van Evercooren, A. Exogenous schwann cells migrate, remyelinate and promote clinical recovery in experimental auto-immune encephalomyelitis. PLoS One 7(9):e42667; 2012.